A trans-cinnamic acid-producing Pantoea agglomerans strain and its application

By fermenting trans cinnamic acid-producing pantoea agglomerans HMX01 in industrial hemp, the efficient production of trans cinnamic acid and the effect of inhibiting pathogenic bacteria is achieved, and the existing chemical synthesis process and reaction conditions are solved. A harsh problem.

CN116064303BActive Publication Date: 2024-11-12ECONOMIC CROP RES INST OF HEILONGJIANG ACAD OF AGRI SCI
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202211180424.1
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-09-26
Publication Date
2024-11-12
Estimated Expiration
2042-09-26

AI Technical Summary

Technical Problem

The existing chemical synthesis of trans cinnamic acid has a long process and harsh reaction conditions, making it difficult to achieve efficient production.

Method used

Pantoea agglomerans HMX01, which produces trans cinnamic acid, is isolated and purified in industrial hemp by fermentation, and uses its good antibacterial activity and metabolite trans cinnamic acid to prepare drugs that inhibit bacteria and fungi.

Benefits of technology

The efficient production of trans cinnamic acid is achieved, and it has a good effect on pathogenic bacteria such as E. coli, Staphylococcus aureus and Pseudomonas aeruginosa, simplifies the process flow and reduces the harshness of the reaction conditions.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN116064303B_ABST
    Figure CN116064303B_ABST
Patent Text Reader

Abstract

A strain of Pantoea agglomerans producing trans-cinnamic acid and its application, relate to the field of microorganisms, and in particular to a strain of Pantoea agglomerans producing trans-cinnamic acid and its application. The purpose is to solve the problem that the existing method for chemically synthesizing trans-cinnamic acid has a long process flow and relatively harsh reaction conditions. The agglomerans is Pantoea agglomerans HMX01, which has been preserved in the China Center for Type Culture Collection on May 26, 2022, and the preservation number is CCTCC NO: 2022721. The agglomerans of the present invention can inhibit bacteria and fungi, and its fermentation broth contains trans-cinnamic acid. The agglomerans of the present invention are used for antibacterial and fermentation to produce trans-cinnamic acid.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of microorganisms, and in particular to a strain of Pantoea agglomerans producing trans-cinnamic acid and application thereof. Background Art

[0002] Pantoea agglomerans is ubiquitous in nature and is usually characterized as a pathogenic bacterium, which limits the development of this type of microorganism to a certain extent. With the in-depth study of Pantoea agglomerans, it was found that this type of strain has the characteristics of phosphate solubilization, nitrogen fixation, strong colonization ability, good stress resistance, and hydrogen production; at the same time, Pantoea agglomerans can also produce secondary metabolites such as antimalarial alkaloids, lipopolysaccharides, peptides, etc., which has caused this strain to begin to attract widespread attention.

[0003] Trans-cinnamic acid is an important organic acid. It is mainly used to prepare spices, such as cherry, apricot, and bee flavors. It can also be used to preserve fresh fruits and vegetables. As an organic synthesis intermediate, it is mainly used in the pharmaceutical industry and can be used to produce L-phenylalanine, the main raw material of aspartame. Cinnamic acid is also used in the preparation of the anti-tumor drug dopaclitaxel. It can also be used to make local anesthetics, bactericides, hemostatics, etc. In terms of pesticides, it can be used as a growth promoter and long-acting bactericide for the preservation of fruits and vegetables.

[0004] The existing method for obtaining trans-cinnamic acid is mainly through chemical synthesis. Benzaldehyde and acetic anhydride are heated in the presence of sodium acetate. After the reaction is completed, steam is introduced to evaporate the benzaldehyde, and then caustic soda is used for neutralization and centrifugation. The obtained sodium cinnamate and sodium acetate solution is subjected to acid precipitation to obtain cinnamic acid, which is then recrystallized with boiling water to obtain a refined product. Therefore, the existing method for chemically synthesizing trans-cinnamic acid has the problems of long process flow and relatively harsh reaction conditions. Summary of the invention

[0005] The invention aims to solve the problems of long process flow and harsh reaction conditions in the existing chemical synthesis method of trans-cinnamic acid, and provides a Pantoea agglomerans producing trans-cinnamic acid and application thereof.

[0006] The present invention provides a trans-cinnamic acid-producing Pantoea agglomerans, which is Pantoea agglomerans HMX01, which has been deposited in the China Center for Type Culture Collection, the deposit address is Wuhan University, Wuhan, the deposit date is May 26, 2022, and the deposit number is CCTCC NO: 2022721.

[0007] The colonies of the Pantoea agglomerans HMX01 of the present invention are smooth, transparent, produce yellow pigment, are round, and have clear and irregular edges.

[0008] The Pantoea agglomerans HMX01 of the present invention is a Gram-negative bacterium, the bacterium is rod-shaped, facultative anaerobic, has flagella, is positive in a starch hydrolysis test, a gelatin liquefaction test, a catalase test, a VP test, a biofilm formation test, an optimum growth temperature of 37°C, an optimum salt tolerance of 4%, and an optimum pH of 6.

[0009] The 16S rDNA sequencing results of the Pantoea agglomerans HMX01 of the present invention were submitted to the NCBI database, analyzed and compared using BLAST, and then a phylogenetic tree of the Pantoea agglomerans HMX01 was constructed using MEGA7 software. The similarity between the Pantoea agglomerans HMX01 and pantoea agglomerans MT605813 reached 100%. Based on the morphological observation results, the Pantoea agglomerans HMX01 was identified as a member of the genus Pantoea, Pantoea agglomerans.

[0010] The present invention also provides the use of Pantoea agglomerans HMX01 in preparing drugs for inhibiting bacteria.

[0011] Furthermore, the bacteria are Staphylococcus aureus, Bacillus brevis, Bacillus subtilis, Listeria monocytogenes, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa.

[0012] The present invention also provides the use of Pantoea agglomerans HMX01 in preparing a drug for inhibiting fungi.

[0013] Furthermore, the fungus is Candida albicans.

[0014] The Pantoea agglomerans HMX01 of the present invention is used for fermentation to produce trans-cinnamic acid.

[0015] Beneficial effects of the present invention:

[0016] The present invention separates and purifies an endophytic bacterium HMX01 from industrial hemp, which is identified as Pantoea agglomerans. Pantoea agglomerans HMX01 has good antibacterial activity, and has a good inhibitory effect on Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa and Listeria monocytogenes.

[0017] The present invention finds that the fermentation liquid of Pantoea agglomerans HMX01 contains trans-cinnamic acid, and it is thus inferred that Pantoea agglomerans HMX01 is a trans-cinnamic acid producing bacterium and can be used to produce trans-cinnamic acid by fermentation. BRIEF DESCRIPTION OF THE DRAWINGS

[0018] Figure 1 This is the colony morphology of Pantoea agglomerans HMX01;

[0019] Figure 2 This is the three-zone line map of Pantoea agglomerans HMX01;

[0020] Figure 3 This is the microscopic morphology of Pantoea agglomerans HMX01;

[0021] Figure 4 16S rDNA PCR results of Pantoea agglomerans HMX01;

[0022] Figure 5 is the phylogenetic tree of Pantoea agglomerans HMX01;

[0023] Figure 6 These are the results of HPLC analysis of the fermentation broth of Pantoea agglomerans HMX01. DETAILED DESCRIPTION

[0024] The embodiments of the present invention are described in detail below. The following embodiments are implemented on the premise of the technical solution of the present invention, and detailed implementation schemes and specific operation processes are given, but the protection scope of the present invention is not limited to the following embodiments.

[0025] Embodiment 1:

[0026] The Pantoea agglomerans HMX01 in this embodiment is Pantoea agglomerans HMX01, which has been deposited in the China Center for Type Culture Collection, the deposit address is Wuhan University, Wuhan, the deposit date is May 26, 2022, and the deposit number is CCTCC NO: 2022721.

[0027] The method for obtaining Pantoea agglomerata HMX01 in this embodiment is as follows:

[0028] Take industrial hemp (Cannabis sativa L.) leaves (Longma No. 5, collected from the Science and Technology Innovation Farm of Suihua Branch of Heilongjiang Academy of Agricultural Sciences) and disinfect the surface according to the following procedures: 75% alcohol 30s-sterile water washing-NaClO 5min-sterile water washing-75% alcohol 30s-sterile water washing. Then grind the experimental materials into homogenate, dilute with distilled water, spread and inoculate in NA medium, and culture at 37°C for 3-5 days. The last distilled water wash in the disinfection process was removed and spread and inoculated on NA medium as a control. Finally, the industrial hemp endophytes, namely strain HMX01, were isolated from the industrial hemp leaves. No bacteria grew in the negative control plate culture medium, and this was repeated many times, thus proving that the bacteria were industrial hemp endophytes.

[0029] Example 2: Identification of strain HMX01

[0030] Morphological observation and 16S rDNA sequence analysis were used.

[0031] The colony morphology of strain HMX01 is as follows Figure 1 As shown, the three-zone demarcation results are as follows Figure 2 The microscopic morphology of hyphae is shown in Figure 3. The colonies of strain HMX01 are smooth, transparent, produce yellow pigment, are round, and have clear and irregular edges.

[0032] The results of physiological and biochemical tests of strain HMX01 are shown in Table 1.

[0033] Table 1 Morphological and physiological and biochemical test results of strain HMX01

[0034]

[0035] The genomic DNA of strain HMX01 was extracted and PCR amplified to obtain a 16S rDNA sequence with a length of 1368 bp. Figure 4 As shown in the figure, 1 represents Marker and 2 represents HMX01. Shanghai Shenggong Biotechnology Co., Ltd. was commissioned to sequence the 16S rDNA of strain HMX01. The 16S rDNA sequence is shown in SEQ ID NO: 1 in the sequence table.

[0036] 16S rDNA sequence of strain HMX01:

[0037] TGGGTGACGAGTGGCGGACGGGTGAGTAATGTCTGGGGATCTGCCCGATAGAGGGGGATAACCACTGGAAACG GTGGCTAATACCGCATAACGTCGCAAGACCAAAGAGGGGGACCTTCGGGCCTCTCACTATCGGATGAACCCAGATGGGATTAGCTAGTAGGCGGGGTAATGGCCCACCTAGGCGACGATCCCTAGCTGGTCTGAGAGGATGACCAGCCACACTG GAACTGAGACACGGTCCAGACTCCTACGGGAGGCAGCAGTGGGGAATATTGCACAATGGGCGCAAGCCTGATGCAGCCATGCCGCGTGTATGAAGAAGGCCTTCGGGTTGTAAAGTACTTTCAGCGGGGAGGAAGGCGACGGGGTTAATAACCC TGTCGATTGACGTTACCCGCAGAAGAAGCACCGGCTAACTCCGTGCCAGCAGCCGCGGTAATACGGAGGGTGCAAGCGTTAATCGGAATTACTGGGCGTAAAGCGCACGCAGGCGGTCTGTTAAGTCAGATGTGAAATCCCCGGGCTTAACCTG GGAACTGCATTTGAAACTGGCAGGCTTGAGTCTTGTAGAGGGGGGTAGAATTCCAGGTGTAGCGGTGAAATGCGTAG AGATCTGGAGGAATACCGGTGGCGAAGGCGGCCCCCTGGACAAAGACTGACGCTCAGGTGCGAAAGCGTGGGGAGCA AACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACGATGTCGACTTGGAGGTTGTTCCCTTGAGGAGTGGCTTCCGGAGCTAACGCGTTAAGTCGACCGCCTGGGGAGTACGGCCGCAAGGTTAAAACTCAAATGAATTGACGGGGGCCCGCACAAGCGGTGGAGCATGTGGTTTAATTCGATGCAACGCGAAGAACCTTACCTACTCTTGACATCCACGGAATTTGGCAGAGATGCCTTAGTGCCTTCGGGAACCGTGAGACAGGTGCTGCATGGCTGTCGTCAGCTCGTGTTGTGAAATGTTGG GTTAAGTCCCGCAACGAGCGCAACCCTTATCCTTTGTTGCCAGCGATTCGGTCGGGAACTCAAAGGAGACTGCCGGTGATAAACCGGAGGAAGGTGGGGATGACGTCAAGTCATCATGGCCCTTACGAGTAGGGCTACACACGTGCTACAATGG CGCATACAAAGAGAAGCGACCTCGCGAGAGCAAGCGGACCTCACAAAGTGCGTCGTAGTCCCGGATCGGAGTCTGCAACTCGACTCCGTGAAGTCGGAATCGCTAGTAATCGTGGATCAGAATGCCACGGTGAATACGTTCCCGGGCCTTGTACA CACCGCCCGTCACACCATGGGAGTGGGTTGCAAAAGAAGTAGGTAGCTTAACCTTCGGGAGGG

[0038] The sequencing results were submitted to the NCBI database, analyzed and aligned using BLAST, and then the phylogenetic tree of strain HMX01 was constructed using MEGA 7 software, as shown in Figure 5 As shown. Figure 5 It can be seen that the similarity between strain HMX01 and pantoea agglomerans MT605813 reached 100%. Based on the morphological observation results, strain HMX01 was identified as Pantoea, Pantoea agglomerans.

[0039] Example 3: Analysis of antibacterial activity of Pantoea agglomerans HMX01:

[0040] 1. Activation of Pantoea agglomerata HMX01:

[0041] Take the clumping Pantoea HMX01, inoculate it onto NA medium under sterile conditions, and culture it at 37°C for 3 days for later use.

[0042] 2. Preparation of Pantoea agglomerata HMX01 fermentation broth:

[0043] Take the activated Pantoea agglomerata HMX01, pick the mycelium under sterile conditions and inoculate it into 50 mL NB medium, and culture it in a shaking incubator at 37°C and 120 r / min for 3 days to make 1×10 7 CFU / mL of seed liquid; the seed liquid was transferred to 3L sterilized NB medium at a 20% (v / v) inoculation amount, cultured at 37°C, 120r / min shaking for 7 days, and the fermentation liquid was filtered.

[0044] 3. Preparation of test solution:

[0045] Take the fermentation liquid of Pantoea agglomerans HMX01 and concentrate it to 50 mL under reduced pressure at 50°C, add 50 mL of methanol, and perform ultrasonic extraction 3 times to obtain the extract, which is concentrated to dryness under reduced pressure, and dissolved with 10 mL of methanol, and used as the test solution for later use. Take appropriate amounts of streptomycin and nystatin powder, add appropriate amounts of methanol to dissolve them, and prepare 200 μg / mL positive control solution for later use.

[0046] 4. Preparation of plates containing test strains

[0047] Take the activated test bacteria: Staphlococcus aureus, Bacillus pumilus, Bacillus subtilis, Listeria monocytogenes, Enterococcus facalis, Enterococcus faecium, Escherichia coli, Klebsiella pneumoniae, Acinetobacter baummanii, Pseudomonas aeruginosa, inoculate in NA test tube slant, culture at 37℃ for 1 day; take the activated test fungus Candida albicans, inoculate in PDA test tube slant, culture at 28℃ for 3 days, and set aside. The above test strains were purchased from Heilongjiang Institute of Microbiology.

[0048] Take the activated test strains mentioned above, add appropriate amount of sterile water, shake and dilute each strain to 1×10 7 Pour the bacterial suspension of 0.1 CFU / mL into the corresponding culture medium and dispense it into sterile plates with Oxford cups. After it solidifies, take out the Oxford cups and set aside.

[0049] 5. Antibacterial activity analysis:

[0050] Accurately add 150 μL of the test solution, positive control solution, and negative control solution to the two wells of the prepared bacteria-containing plate. The plate containing bacteria was incubated at 37°C for 1 day, and then the diameter of the inhibition zone was measured (n=3); the plate containing fungi was incubated at 28°C for 3 days, and then the diameter of the inhibition zone was measured (n=3).

[0051] Experimental results:

[0052] The antibacterial activity results of Pantoea agglomerans HMX01 are shown in Table 2.

[0053] Table 2 Antibacterial activity results of the fermentation broth of Pantoea agglomerata HMX01

[0054]

[0055]

[0056] Note: A: Escherichia coli; B: Bacillus subtilis; C: Staphylococcus aureus; D: Bacillus pumilus; E: Pseudomonas aeruginosa; F: Listeria monocytogenes; G: Klebsiella pneumoniae; H: Acinetobacter baumannii; I: Enterococcus faecium; J: Enterococcus faecalis; K: Candida albicans; Str: Streptomycin; Nys: Nystatin.

[0057] From the results in Table 2, it can be seen that Pantoea agglomerans HMX01 has inhibitory effects on 11 strains of pathogenic bacteria, among which the inhibitory effects on Escherichia coli, Staphlococcus aureus, Pseudomonas aeruginosa and Listeria monocytogenes are significantly stronger than those of the positive control drug.

[0058] Example 4: HPLC analysis of Pantoea agglomerans HMX01 fermentation broth:

[0059] 1. Preparation of test solution

[0060] Take the activated Pantoea agglomerata HMX01, pick the mycelium under sterile conditions and inoculate it into 50 mL NB medium, and culture it in a shaking incubator at 37°C and 120 r / min for 3 days to make 1×10 7 CFU / mL seed liquid; the seed liquid was transferred to 300mL of sterilized NB medium at an inoculum size of 20% (v / v), and cultured in a shaking incubator at 37°C and 120r / min for 7d, the fermentation broth was filtered out, and concentrated under reduced pressure at 50°C, the concentrated fermentation broth was extracted 3 times with ethyl acetate (3×100mL), the extracts were combined, concentrated to dryness at 50°C, and dissolved in 1mL of methanol as the test solution for later use.

[0061] 2. Preparation of reference solution

[0062] Accurately weigh 0.5 mg of each trans-cinnamic acid reference substance, place it in a 1 mL centrifuge tube, add 1 mL of chromatographic methanol to dissolve, and prepare the reference substance solution for use.

[0063] 3. Preparation of blank control solution

[0064] Take 300 mL of NB culture medium and concentrate it under reduced pressure at 50°C. Extract the concentrated NB culture medium with ethyl acetate three times (3×100 mL). Combine the extracts, concentrate to dryness at 50°C, dissolve them in 1 mL of methanol and use them as blank control solution for later use.

[0065] 4. HPLC conditions

[0066] Chromatographic column: Venusil XBP-C 18 Column (4.6 mm × 250 mm, 5 μm, USA) Mobile phase: methanol-0.1% formic acid (65:35) Flow rate: 1 mL·min -1 ; Column temperature: 25℃; Detection wavelength: 220nm; Injection volume: 10μL.

[0067] 5. HPLC analysis results of Pantoea agglomerans HMX01 fermentation broth:

[0068] The fermentation broth of Pantoea agglomerans HMX01 was analyzed by HPLC, with trans-cinnamic acid as the reference substance. The HPLC results are shown in FIG6 . Figure 6 A represents HMX01 fermentation broth, B represents trans-cinnamic acid reference substance, and C represents NB sample.

[0069] Depend on Figure 6 It can be seen that the fermentation broth of Pantoea agglomerans HMX01 test sample and trans-cinnamic acid reference substance have the same chromatographic peak at the same retention time, and the blank control (NB) has no interference. The trans-cinnamic acid reference substance was added to the HMX01 test solution by the standard addition method, and the result of HPLC analysis was still a single chromatographic peak at the same retention time position as the reference substance trans-cinnamic acid. Therefore, it was preliminarily determined that trans-cinnamic acid was contained in the HMX01 fermentation broth, and it was speculated that Pantoea agglomerans HMX01 may be a trans-cinnamic acid producing bacterium.

Claims

1. A Pantoea agglomerans strain producing trans-cinnamic acid, characterized in that The agglomerans is Pantoea agglomerans HMX01, which has been deposited in the China Center for Type Culture Collection, the deposit address is Wuhan University, Wuhan, the deposit date is May 26, 2022, and the deposit number is CCTCC NO: 2022721.

2. Use of Pantoea agglomerans HMX01 as claimed in claim 1 in the preparation of drugs for inhibiting bacteria; the bacteria are Staphylococcus aureus, Bacillus brevis, Bacillus subtilis, Listeria monocytogenes, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa.

3. Use of Pantoea agglomerans HMX01 as claimed in claim 1 in the preparation of a drug for inhibiting fungi; the fungus is Candida albicans.

4. The Pantoea agglomerata HMX01 as described in claim 1 is used for fermentation to produce trans-cinnamic acid.

Citation Information

Patent Citations

  • Pantoea agglomeran new bacterial strain XM2, preparation method for suspension of same, and method for controlling pear black spot

    CN103952338A

  • Pantoea agglomerans strain and application thereof

    CN110713951A

  • L-glutamic acid-producing bacterium and production of l-glutamic acid

    JP2000106869A

  • An l-glutamic acid producing bacterium and a method for producing l-glutamic acid

    WO2008020654A2